Results 51 to 60 of about 162,186 (348)

Quantitative Proteomics to study Carbapenem Resistance in Acinetobacter baumannii

open access: yesFrontiers in Microbiology, 2014
Acinetobacter baumannii is an opportunistic pathogen causing pneumonia, respiratory infections and urinary tract infections. The prevalence of this lethal pathogen increases gradually in the clinical setup where it can grow on artificial surfaces ...
Vishvanath eTiwari, Monalisa eTiwari
doaj   +1 more source

Detection and Typing of Plasmids in Acinetobacter baumannii Using rep Genes Encoding Replication Initiation Proteins

open access: yesbioRxiv, 2022
Though they contribute to the dissemination of genes that confer resistance to clinically important carbapenem and aminoglycoside antibiotics used to treat life-threatening Acinetobacter baumannii infections, plasmids found in Acinetobacter species have ...
M. Lam   +4 more
semanticscholar   +1 more source

Establishment and preliminary application of a rapid pathogen-specific phenotypic antibiotic susceptibility test for Acinetobacter baumannii

open access: yesDi-san junyi daxue xuebao, 2021
Objective To establish a rapid phenotypic antibiotic susceptibility testing of Acinetobacter baumannii based on surfactant-propidium monoazide (PMAxx)-qPCR reaction system.
LUO Dan   +3 more
doaj   +1 more source

Human Pleural Fluid Elicits Pyruvate and Phenylalanine Metabolism in Acinetobacter baumannii to Enhance Cytotoxicity and Immune Evasion [PDF]

open access: yes, 2019
The CCAAT box-harboring proteins represent a family of heterotrimeric transcription factors which is highly conserved in eukaryotes. In fungi, one of the particularly important homologs of this family is the Hap complex that separates the DNA-binding ...
Bonomo, Robert A.   +15 more
core   +1 more source

Managing Acinetobacter baumannii infections

open access: yesCurrent Opinion in Infectious Diseases, 2019
Purpose of review We reviewed recent data about epidemiology of Acinetobacter baumannii, resistance mechanisms, and therapeutic options for severe infections caused by multidrug-resistant strains. Recent findings A.
Garnacho-Montero, José   +1 more
openaire   +3 more sources

Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline

open access: yesJournal of Clinical Pharmacy and Therapeutics, 2022
Acinetobacter baumannii is one of the most important nosocomial pathogens with the ability to cause infections such as meningitis, pneumonia, urinary tract, septicaemia and wound infections.
R. Dehbanipour, Z. Ghalavand
semanticscholar   +1 more source

In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant acinetobacter baumannii [PDF]

open access: yes, 2019
Carbapenem-resistant Acinetobacter baumannii (CR-Ab) infections are associated with high morbidity and mortality. The aim of the study was to evaluate the in-vitro activity of different antimicrobial combinations (with and without colistin, COL) against ...
De Angelis, Massimiliano   +6 more
core   +1 more source

Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit

open access: yesInfection, 2021
Objectives Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-
A. Russo   +8 more
semanticscholar   +1 more source

Ultrafast Structural Dynamics of BlsA, a Photoreceptor from the Pathogenic Bacterium Acinetobacter baumannii [PDF]

open access: yes, 2014
Acinetobacter baumannii is an important human pathogen that can form biofilms and persist under harsh environmental conditions. Biofilm formation and virulence are modulated by blue light, which is thought to be regulated by a BLUF protein, BlsA.
Adelbert Bacher   +45 more
core   +2 more sources

Multidrug-ResistantAcinetobacter baumannii

open access: yesEmerging Infectious Diseases, 2005
To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and define individual risk factors for multidrug resistance, we used epidemiologic methods, performed organism typing by pulsed-field gel electrophoresis (PFGE), and conducted a matched case-control retrospective study.
Aharon Abbo   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy